Severe refractory hidradenitis suppurativa in an HIV-positive patient successfully treated with infliximab. [electronic resource]
- Archives of dermatology Dec 2010
- 1343-5 p. digital
Publication Type: Case Reports; Journal Article
1538-3652
10.1001/archdermatol.2010.372 doi
Anti-Inflammatory Agents--administration & dosage Antibodies, Monoclonal--administration & dosage Dose-Response Relationship, Drug HIV Antibodies--analysis HIV Seropositivity--complications HIV-1--genetics Hidradenitis Suppurativa--complications Humans Infliximab Male Middle Aged RNA, Viral--analysis Severity of Illness Index Tumor Necrosis Factor-alpha--antagonists & inhibitors